Advertisement

Topics

Keeping Track: US FDA Refuses To File Acorda, SteadyMed NDAs

08:03 EDT 4 Sep 2017 | SCRIP

Issues involving inspectional readiness and the drug master production record cited in agency's refusal to review Acorda's Inbrija in Parkinson's...

      

Related Stories

 

Original Article: Keeping Track: US FDA Refuses To File Acorda, SteadyMed NDAs

NEXT ARTICLE

More From BioPortfolio on "Keeping Track: US FDA Refuses To File Acorda, SteadyMed NDAs"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...